Old Web
English
Sign In
Acemap
>
authorDetail
>
T. Kasparek
T. Kasparek
Novartis
Dermatology
Medicine
Concomitant
Psoriasis
Secukinumab
4
Papers
23
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
10th European Hidradenitis Suppurativa (EHSF) e.V. Conference.
2021
Experimental Dermatology
E Muscianisi
A. C. Potocki
D Keefe
N Thomas
T. Kasparek
Alexa B. Kimball
A B Gottlieb
Afsaneh Alavi
Z. Reguiai
Gregor B. E. Jemec
Show All
Source
Cite
Save
Citations (0)
Secukinumab is effective in treatment of moderate to severe plaque psoriasis: Real‐life effectiveness and safety from the PROSPECT study
2019
Journal of The European Academy of Dermatology and Venereology
Diamant Thaçi
Andreas Körber
R. von Kiedrowski
Teresa Bachhuber
Nima Melzer
T. Kasparek
E. Duetting
G. Kraehn-Senftleben
U. Amon
Matthias Augustin
Show All
Source
Cite
Save
Citations (11)
Secukinumab treatment of moderate to severe plaque psoriasis in routine clinical care: Real-life data of prior and concomitant use of psoriasis treatments from the PROSPECT study
2018
Journal of The European Academy of Dermatology and Venereology
A. Körber
Diamant Thaçi
R. von Kiedrowski
T. Bachhuber
Nima Melzer
T. Kasparek
G. Kraehn-Senftleben
U. Amon
Matthias Augustin
Show All
Source
Cite
Save
Citations (12)
1